QA: NEOGEN CORP in us_medicinal_products/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000711377_2022_NEOGEN_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000711377, NEOGEN CORP

  xvar xval
0 LiabilitiesNoncurrent 4,299,000
1 LiabilitiesCurrent 75,516,000
2 remainder_Liabilities 0
3 AssetsCurrent 591,451,000
4 AssetsNoncurrent 4,496,000
5 PropertyPlantAndEquipmentNet 100,453,000
6 Goodwill 208,247,000
7 remainder_Assets 15,545,000
8 GeneralAndAdministrativeExpense 378,043,000
9 ResearchAndDevelopmentExpense 16,247,000
10 remainder_Expenses 14,386,000
11 remainder_Revenues 468,459,000
12 remainder_NetIncome 1,099,000
13 remainder_ComprehensiveNetIncome 8,334,000
  yvar yval
0 Liabilities 79,815,000
1 Assets 920,192,000
2 Expenses 408,676,000
3 Revenues 468,459,000
4 StockholdersEquity 840,377,000
5 NetIncome 60,882,000
6 ComprehensiveNetIncome 65,049,000
7 BaseVar 943,287,500
8 EconomicCapitalRatio 1.56

Edgar->Model Mapping

Feature Distribution

Change over Time